Sanofi India Q1 2026 Results: Profit Falls 25% as Sales and Margins Decline
Sanofi India, a well-known name in the Indian pharmaceutical space, has released its financial results for the first quarter of 2026, and the numbers suggest a turbulent start to the financial year. With a steep decline in sales, EBITDA, and net profit, the company is navigating a challenging phase marked by market dynamics, pricing pressures,…
